James Del Rosso, DO: JCAD February 2025 Issue Highlights

JCAD Dialogues and Reviews: Highlighting a Vitiligo Roundtable Discussion in JCAD

JCAD Dialogues and Reviews: Considerations for Antibiotic Adverse Events

James Del Rosso, DO: JCAD January 2025 Issue Highlights

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2025 issue of JCAD.

James Del Rosso, DO: Dermatology Year in Review 2024

Dr. Del Rosso reviews some of the most impactful research developments and drug approvals seen by the dermatology world in 2024.

JCAD Dialogues and Reviews: Spotlight on a Newly Approved Treatment for Rosacea

Dr. Del Rosso discusses efficacy data on a new low-dose, extended release formulation of oral minocycline for rosacea.

James Song, MD: Live from Elevate-Derm West—New Topical and Systemic Agents for Atopic Dermatitis

Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.

James Song, MD: Live from Elevate-Derm West—New Topical and Systemic Agents for Atopic Dermatitis

Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.

James Song, MD: Live from Elevate-Derm West—Why Older Immunosuppressant Agents are Still Relevant in 2024

Dr. Song provides helpful clinical tips for treating patients with methotrexate. 

JCAD October 2024 Issue Highlights

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2024 issue of JCAD. Read the full issue here. 

New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.